|Full title:||Rakeiora Cancer Genomic Medicine Research Pathfinder Study: A pathfinder program to develop and test infrastructure for genomic medicine research in Aotearoa New Zealand.|
|Cancer type:||All cancers including blood cancers|
The aim of the Rakeiora Study is to develop an initial, proof-of-concept, cancer genomic research infrastructure that will be the foundation for a scalable national cancer genomics research infrastructure.
This study plans to recruit 100 participants with any type of cancer. A cancer tissue sample (stored tissue sample or blood sample) and a normal tissue sample (blood sample or nail clipping/cheek swab) will be collected from each participant.
|Lead Investigator:||Professor Cris Print (University of Auckland), Dr Helen Wihongi (Auckland & Waitematā DHB)|
|Contact:||Jade Scott (email@example.com)|
|Sponsor:||University of Auckland|
|Funder:||Ministry of Business, Innovation & Employment (MBIE) through Genomics Aotearoa (GA)|
|Trial Registry reference:||Universal Trial Number (UTN): U1111-1274|
|Ethics number:||2022 EXP 11206|